suicidality | CARLAT PUBLISHING

Addressing Suicidality in Autistic Children and Teens

September 25, 2023

Joshua Feder, MD, Mara Goverman, and Paul Lipkin, MD

Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Autistic kids and teens can become despondent or suicidal. This episode explores the distinction between self-injurious behavior and suicidality in autistic children, communication patterns related to suicide, the screening process for identifying suicidality, and the different levels of care required to effectively address this issue.

RESEARCH UPDATE

Antidepressants for Suicidal Ideation in Depressed Patients?

July 1, 2022

James Black, MD

James Black, MD. Dr. Black has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Antidepressants reduce suicidality even among patients who remain depressed.

Electroconvulsive Therapy: A Primer

March 23, 2022

Stephen J. Seiner, MD

Stephen J. Seiner, MD Director of neurotherapeutics, McLean Hospital. Belmont, MA. Dr. Seiner has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Seiner runs one of the busiest ECT programs in the country and speaks to us about recent innovations in the procedure. He also tells us which patients are the best candidates and shares tips for how to prolong ECT’s benefits.

Intravenous Ketamine for Teen Depression

January 31, 2022

Pavan Madan, MD.

Pavan Madan, MD. Dr. Madan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Ketamine is a hot topic in the treatment of adults with severe depression. But how effective is ketamine in adolescents? This research update looks at some emerging data to help you decide whether off label use of ketamine might be a viable option in teens with severe depression.

Borderline Personality Disorder in the ED

January 7, 2022

Victor Hong, MD

Victor Hong, MD.
Clinical Assistant Professor, Department of Psychiatry, University of Michigan, Ann Arbor, MI.

Dr. Hong has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Patients with borderline personality disorder often show up in emergency rooms multiple times and can trigger frustration and countertransference reactions in clinicians. Dr. Hong tells us how to help these patients and their families develop the skills needed to manage their emotions.

Self-Harm in Adolescents With ADHD

October 18, 2021

Pavan Madan, MD.

Pavan Madan, MD. Dr. Madan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

What is the relationship between ADHD and non-suicidal self-injury? This research update teases out an understanding of these and other common co-morbidities in a manner that suggests a practical approach to dealing with both problems in our child and adolescent patients.

The Effect of Age and Pubertal Stage on Mental Health in Gender-Incongruent Youths

May 20, 2021

John Raiss, MD.

John Raiss, MD. Dr. Raiss has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When is the best time to begin gender affirming medical care (GAMC) with respect to addressing the mental health status of children and adolescents with Gender Dysphoric Disorder? Should we begin Hormone Replacement Therapy early or wait until the adolescent is older? This research update will help you grapple with this very public debate.

Intranasal Esketamine: New Hope for Suicidal Patients?

April 12, 2021

Victoria Hendrick, MD. and Daniel Carlat, MD

Victoria Hendrick, MD.

Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report. Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Imagine a drug that resolves depression within hours in people at imminent risk of suicide. Esketamine may be such a drug — but is it a miracle cure? Here we look at the data and discuss the pros and cons of this new treatment.

Treating Pandemic-Associated Trauma in Children and Adolescents

March 12, 2021

Alan Steinberg, PhD and Naser Ahmadi, MD, PhD

Alan Steinberg, PhD Associate Director of the National Center for Child Traumatic Stress at UCLA.

Naser Ahmadi, MD, PhD Assistant Professor of Psychiatry at UCLA. Dr. Steinberg and Dr. Ahmadi have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In the age of COVID-19, clinicians need to assess for specific pandemic-related impacts on children and adolescents. UCLA has a new COVID-19 PTSD screen and they have also developed an effective intervention that targets and manages trauma triggers to address suicidality in children and adolescents for use in urgent settings.

Tips on the Doubts about Ketamine/Esketamine

August 19, 2020

Ketamine and esketamine have been shown to provide rapid relief of suicidality, however, many lingering doubts have been raised about these medicines. In a previous article from The Carlat Psychiatry Report, Nolan Williams, M.D., discusses the potential negative consequences of ketamine/esketamine treatment. Here are some of Dr. Williams’s tips:It might...